MONICA BYERS: Open Payments
NPI 1225045354 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 15 payments from 8 companies in 2025. Trend: 2023 $32 · 2024 $65 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $186 |
| Janssen Pharmaceuticals, Inc | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Alkermes, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: SPRAVATO, VRAYLAR, REXULTI, COBENFY, LYBALVI, Auvelity, AUSTEDO XR, CAPLYTA.
Industry payments across OR — which companies pay providers there.
